(Q53905861)

22 May 2018

title

Empiric oral monotherapy for hospitalized patients with community-acquired pneumonia: an idea whose time has come. (English)

1 reference

22 May 2018

0 references

1 reference

B A Cunha

1

1 reference

22 May 2018

publication date

15 January 2004

1 reference

22 May 2018

European Journal of Clinical Microbiology & Infectious Diseases

published in

1 reference

22 May 2018

volume

23

1 reference

22 May 2018

issue

2

1 reference

22 May 2018

page(s)

78-81

1 reference

22 May 2018

Sparfloxacin versus clarithromycin in the treatment of community-acquired pneumonia

cites work

1 reference

12 December 2020

Early switch from intravenous to oral cephalosporins in the treatment of hospitalized patients with community-acquired pneumonia

1 reference

12 December 2020

Antibiotic therapy in pneumonia: a comparative study of parenteral and oral administration of penicillin

1 reference

12 December 2020

Efficacy and safety of oral and early-switch therapy for community-acquired pneumonia: a randomized controlled trial

1 reference

12 December 2020

Infectious disease outbreaks in nursing homes: an unappreciated hazard for frail elderly persons

1 reference

12 December 2020

Pharmacoeconomic Benefit of Antibiotic Step-Down Therapy: Converting Patents from Intravenous Ceftriaxone to Oral Cefpodoxime Proxettl

1 reference

12 December 2020

Trovafloxacin versus high-dose amoxicillin (1 g three times daily) in the treatment of community-acquired bacterial pneumonia

1 reference

12 December 2020

Oral or intravenous-to-oral antibiotic switch therapy for treating patients with community-acquired pneumonia

1 reference

12 December 2020

Oral moxifloxacin vs high-dosage amoxicillin in the treatment of mild-to-moderate, community-acquired, suspected pneumococcal pneumonia in adults

1 reference

12 December 2020

Oral versus intravenous antibiotics for community acquired lower respiratory tract infection in a general hospital: open, randomised controlled trial

1 reference

12 December 2020

Effective antibiotic-resistance control strategies

1 reference

12 December 2020

Strategies to control antibiotic resistance

1 reference

12 December 2020

Clinical features of legionnaires' disease

1 reference

12 December 2020

Clinical relevance of penicillin-resistant Streptococcus pneumoniae

1 reference

12 December 2020

A comparative study of levofloxacin and ceftriaxone in the treatment of hospitalized patients with pneumonia

1 reference

12 December 2020

Full-course oral levofloxacin for treatment of hospitalized patients with community-acquired pneumonia

1 reference

12 December 2020

Treatment of community-acquired pneumonia: a randomized comparison of sparfloxacin, amoxycillin-clavulanic acid and erythromycin

1 reference

12 December 2020

Early Switch From Intravenous to Oral Antibiotics and Early Hospital Discharge

1 reference

12 December 2020

A prospective randomized study of inpatient iv. antibiotics for community-acquired pneumonia. The optimal duration of therapy

1 reference

12 December 2020

Intravenous/oral sequential therapy in patients hospitalised with community-acquired pneumonia: which patients, when and what agents?

1 reference

12 December 2020

Community-acquired pneumonia: reality revisited

1 reference

12 December 2020

A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia

1 reference

12 December 2020

10.1007/S10096-003-1061-9

Identifiers

DOI

1 reference

22 May 2018

release_tkz3qeqxivcpxlaiggmt6kh6zy

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tkz3qeqxivcpxlaiggmt6kh6zy

24 November 2022

mapped directly with Wikidata item

1 reference

22 May 2018